Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy
Open accessThe DOI matches its Crossref record; 644 of the 644 references it cites were found in a registry or an index.
Abstract
The aim of this review is to propose a Unified Theory of Alzheimer's disease (UTAD) that integrates all key behavioural, genetic and environmental risk factors in a causal chain of etiological and pathogenetic events. It is based on three concepts that emanate from human's evolutionary history: (1) The grandmother-hypothesis (GMH), which explains human longevity due to an evolutionary advantage in reproduction by trans-generational transfer of acquired knowledge. Consequently it is argued that mental health at old-age must be the default pathway of humans' genetic program and not development of AD. (2) Therefore, mechanism like neuronal rejuvenation (NRJ) and adult hippocampal neurogenesis (AHN) that still function efficiently even at old age provide the required lifelong ability to memorize personal experiences important for survival. Cumulative evidence from a multitude of experimental and epidemiological studies indicate that behavioural and environmental risk factors, which impair productive AHN, result in reduced episodic memory performance and in reduced psychological resilience. This leads to avoidance of novelty, dysregulation of the hypothalamic-pituitary-adrenal (HPA)-axis and cortisol hypersecretion, which drives key pathogenic mechanisms of AD like the accumulation and oligomerization of synaptotoxic amyloid beta, chronic neuroinflammation and neuronal insulin resistance. (3) By applying to AHN the law of the minimum (LOM), which defines the basic requirements of biological growth processes, the UTAD explains why and how different lifestyle deficiencies initiate the AD process by impairing AHN and causing dysregulation of the HPA-axis, and how environmental and genetic risk factors such as toxins or ApoE4, respectively, turn into disease accelerators under these unnatural conditions. Consequently, the UTAD provides a rational strategy for the prevention of mental decline and a system-biological approach for the causal treatment of AD, which might even be curative if the systemic intervention is initiated early enough in the disease process. Hence an individualized system-biological treatment of patients with early AD is proposed as a test for the validity of UTAD and outlined in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Decades of intensive research on a relatively narrow set of pathogenic processes occurring in the brain and body have produced few effective new drugs or other significant advances in the prevention and treatment of Alzheimer’s disease and related dementias (ADRD).1–3”
From Why the cognitive ‘fountain of youth’ may be upstream: pathways to dementia risk and resilience through social connectedness (2022) · cites this paper as [2]
Experimental — accuracy not yet measuredIn the citing paper
“Neurologists have argued that any successful intervention for ADRD must target multiple pathophysiological processes simultaneously.2”
From Why the cognitive ‘fountain of youth’ may be upstream: pathways to dementia risk and resilience through social connectedness (2022) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Rao, J. S., Ertley, R. N., Lee, H.-J., DeMar, J. C., Arnold, J. T., Rapoport, S. I., & Bazinet, R. P. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001888 · Cited by 279 · cited 1×
“DHA depletion has been shown to result in decreased BDNF levels [513], in impeded productive AHN [514] and in neuroinflammation [308].”
BackgroundRetractedGao, Y., Huang, C., Zhao, K., Ma, L., Qiu, X., Zhang, L., Xiu, Y., Chen, L., Lu, W., Huang, C., et al. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3845 · Cited by 155
RetractedRetracted: Nutrition, adult hippocampal neurogenesis and mental health
Zainuddin, M. S. A., & Thuret, S. (2012) · British Medical Bulletin · doi:10.1093/bmb/lds021 · Cited by 116 · cited 1×
“There is a long list of nutrients that are essential building blocks for (adult) neurogenesis and synaptogenesis (for review, see [264]) and which are also important for NRJ.”
BackgroundRetractedChae, C.-H., Lee, H.-C., Jung, S.-L., Kim, T., Kim, J.-H., Kim, N.-J., & Kim, H.-T. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.030 · Cited by 29
RetractedNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“It is of interest that in AD, the perirhinal (PRH) and lateral entorhinal cortex (LEC) of the HC are among the first cortical regions to be affected [160, 161].”
BackgroundThe Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Research works printed but not linked: 5
- Boyd W. A textbook of pathology: an introduction to medicine, Lea and febiger. 1938.
- Sprengel PC. Von der Substanz der Ackerkrume und des Untergrundes. Leipzig: Journal für Technische und Ökonomische Chemie; 1828.
- Jørgensen JR, Fjord-Larsen L, Wahlberg LU, Andrade NGM, Johansen TE. Therapeutic use of a growth factor. METRNL US-patent. 2012;8334264:B2.
- Miklossy J.J. Neuroinflammation. Alzheimer’s disease - a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. 2011;8:90. doi: 10.1186/1742-2094-8-90 . · DOI · Paper page
- Nakano M, et al. Effect of pyrroloquinoline quinone (PQQ) on mental status of middle-aged and elderly persons. Food Style. 2009;13:50–3.
Cited by
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Mathew, G. E., Uddin, M. S., Kim, H., & Mathew, B. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13132 · Cited by 154
Neuroinflammation—A Crucial Factor in the Pathophysiology of Depression—A Comprehensive Review
Sălcudean, A., Bodo, C.-R., Popovici, R. A., Lica, M. M., Păcurar, M., Crăciun, R.-E., Crișan, A., ENĂTESCU, V. R., Marinescu, I. P., Cîmpian, D. M., et al. (2025) · Biomolecules · doi:10.3390/biom15040502 · Cited by 197
“Elevated cortisol levels have been linked to increased neuroin fl ammation in conditions such as Alzheimer’s disease, in which in fl ammation is considered a feature of the disease process [312].”
The Immunopathogenesis of Alzheimer’s Disease Is Related to the Composition of Gut Microbiota
Leblhuber, F., Ehrlich, D., Steiner, K., Geisler, S., Fuchs, D., Lanser, L., & Kurz, K. (2021) · Nutrients · doi:10.3390/nu13020361 · Cited by 157
Nanomedicine: A Promising Way to Manage Alzheimer’s Disease
Khan, N. H., Mir, M., Ngowi, E. E., Zafar, U., Khakwani, M. M. A. K., Khattak, S., Zhai, Y., Jiang, E., Zheng, M., Duan, S., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.630055 · Cited by 88
“Although the mechanisms of this association are complex, it is considered that hypertension can influence AD through the association of cerebrovascular pathology (Diaz-Ruiz et al., 2009; Nehls, 2016).”
Background
Metadata
- Authors
- Nehls, M.
- Corresponding author
- Nehls, Michael
- ORCID
- Nehls, Michael
- Venue
- Journal of Molecular Psychiatry
- Published
- 2016-07-15
- Volume
- 4
- Issue
- 1
- Pages
- 3-3
- ISSN
- 2049-9256 (ISSN-L)
- PMC
- PMC4947325
- OpenAlex
- W2463416598
- Cited by
- 41
- References
- 644
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 1
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Molecular Psychiatry (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Not applicable (Not applicable, independent researcher)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- Alzheimer's disease, grandmother hypothesis, adult hippocampal neurogenesis, HPA axis dysregulation, cortisol hypersecretion, amyloid-beta oligomerization, neuroinflammation, insulin resistance, APOE ε4, law of the minimum, behavioral risk factors, environmental risk factors, episodic memory, psychological resilience, early intervention, curative treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy. https://app.cochat.ai/papers/10.1186/s40303-016-0018-8
- The paper
- Nehls, M. (2016). Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy. Journal of Molecular Psychiatry. https://doi.org/10.1186/s40303-016-0018-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.